Delivery Order SPE2DB22D2005-SPE2DB25FJSC7
- Not listed
- The Defense Logistics Agency awarded a $3,110.77 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Erythromycin 0.5% eye ointment on July 23, 2025, with an ultimate completion date of July 24, 2025. The contract was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $1,174.20 to AmerisourceBergen Drug Corp for Erythromycin 0.5% Eye Ointment on July 18, 2025, with a completion date of July 21, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded through open competition. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. As a child contract under a larger vehicle, this delivery order falls...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Erythromycin 0.5% eye ointment in 3.5-gram units. This firm fixed-price delivery order, valued at $1,180.03, represents a non-competitive, non-set-aside award issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vehicle running through December 2026. The order is...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp for Erythromycin 0.5% eye ointment in 3.5-gram units, with a contract value of $1,362.97 and an ultimate completion date of July 30, 2025. This non-set-aside award reflects a competitive procurement process and represents a delivery order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at approximately $1 billion through December...
- The Defense Logistics Agency awarded a delivery order valued at $4,301.90 to AmerisourceBergen Drug Corp for the supply of Erythromycin 0.5% eye ointment. The contract is firm fixed price with no set-aside designation and an ultimate completion date of July 31, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Erythromycin 0.5% Eye Ointment in 3.5GM units, with a ceiling value of $1,075.00. This is a firm fixed-price delivery order with no set-aside designation, issued competitively under the contractor's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle valued through December 2026. The place of...
- The U.S. Defense Logistics Agency's Medical Supply Chain has awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp for erythromycin ophthalmic with a ceiling value of $3,098.76. The contract, awarded on November 25, 2024, with an ultimate completion date of November 26, 2024, represents a non-competitive, non-set-aside procurement executed as a child order under AmerisourceBergen's larger indefinite delivery contract vehicle. The work will be performed at the contractor's...
- The Defense Logistics Agency's Medical Supply Chain awarded a $5,902.85 delivery order to AmerisourceBergen Drug Corp on December 22, 2023, for the supply of Erythromycin Ophthalmic. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The work is to be performed at the contractor's corporate office location...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Erythromycin 0.5% Eye Ointment under contract number 4568964193. This firm fixed-price delivery order, valued at $2,475.20, represents a non-set-aside competitive award with an ultimate completion date of August 4, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and serves the Defense Logistics Agency's...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $2,207.94 to AmerisourceBergen Drug Corp for the supply of erythromycin ophthalmic medication. This competitively awarded, non-set-aside contract was issued on December 22, 2023, with an ultimate completion date of December 26, 2023. The place of performance is listed as the contractor's Corporate Office location in Conshohocken, Pennsylvania. The contract employs firm fixed-price pricing and is structured as...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB25FJSC7Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,980.16 to AmerisourceBergen Drug Corp for the supply of Erythromycin 0.5% Eye Ointment (UDGM) on August 19, 2025, with an ultimate completion date of August 20, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion vehicle running through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical procurement vendor specializing in pharmaceutical and medical supply distribution for military and veteran healthcare systems. The company's extensive portfolio of federal contracts demonstrates its capability to fulfill diverse medical supply requirements through open competition, ranging from small-value transactions to substantial orders. This delivery order for erythromycin ophthalmic ointment exemplifies the company's role in supplying essential medications and medical commodities to support the Defense Health Agency and other government healthcare entities through the DLA's flexible contract vehicle structure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 8/19/25 |